Depth determines which tissue region receives the material, while volume controls how much is released at that location. Selecting both parameters allows researchers to adjust local exposure and reduce unintended distribution into nearby or distant tissues. In cancer studies, this control helps distinguish effects caused by treatment at the intended site from effects related to broader material dispersal.
Anatomical targeting links the delivered material to a defined tissue or tumor location. This relationship is important because researchers may need to evaluate local drug activity, tumor behavior, or biological responses at the treated site. Accurate placement also helps limit exposure outside the intended region, making procedure-related effects easier to interpret.
The needle or catheter provides the route for releasing a measured amount of material, while operative guidance helps direct that instrument toward the selected anatomical site. Together, these components support controlled placement and depth selection. Their coordinated use is especially relevant when researchers need localized delivery during an operation rather than broad distribution throughout the body.
Researchers can use the technique to place a therapeutic agent directly within a tumor, creating localized exposure for treatment-response studies. This approach allows investigators to examine how the tumor responds at the treated site while limiting distribution to surrounding or distant tissues. The resulting observations can contribute to evaluations of drug activity and tumor biology.
A biological sample, including tumor cells, can be introduced into a selected anatomical site to support implantation in an animal model. Controlled placement helps associate later observations with the intended site of tumor development. Researchers can then use the model to study tumor biology, assess experimental interventions, and examine effects associated with the injection procedure.
Delivery of therapeutic agents, gene-based or immune-based therapies, and imaging agents can generate different types of cancer research information. Therapeutic materials support treatment-response evaluation, biological agents help investigate tumor-related processes, and imaging agents assist with observing relevant features. Researchers may also assess procedure-related effects alongside tumor biology and response outcomes.